---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-24-000085"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2024-09-04T23:59:59+00:00"
generated_at: "2026-05-31T06:25:39.684193+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Puneet Arora as Chief Medical Officer, grants 225,000 stock options

## Summary
- Puneet S. Arora, MD, appointed CMO effective Sept 3, 2024; base salary $475k with 40% target bonus.
- Received inducement stock option for 225k shares vesting over 4 years (25% at 1-year, then monthly).
- Previously CMO at Lassen Therapeutics, Head of Clinical Dev at Principia (Sanofi), Senior Medical Director at Genentech.
- Company focuses on Phase 2 CBeyond obesity trial for nimacimab, a CB1 inhibitor.
- Also granted 13,500 share non-qualified option to a new non-executive employee under inducement plan.

## SEC filing metadata
- accession: 0001516551-24-000085
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2024-09-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000085/0001516551-24-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000085/skye-20240903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-24-000085
- JSON: https://secwatch.observer/filing/0001516551-24-000085.json
- Plain text: https://secwatch.observer/filing/0001516551-24-000085.txt

## Key facts
- Executive change
  Puneet S. Arora was appointed as Chief Medical Officer at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On September 3, 2024, Skye Bioscience, Inc. (the “Company”) announced the appointment of Puneet S. Arora, MD, MS, FACE, as Chief Medical Officer, effective as of September 3, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000085/0001516551-24-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.